JIAN LIU,JOSEPH A. KOZLOWSKI,ABDUL-BASIT ALHASSAN,SOBHANA BABU BOGA,XIAOLEI GAO,DEODIAL GUY GUIADEEN,JYHSHING WANG,WENSHENG YU,JIAQIANG CAI,SHILAN LIU,DAHAI WANG,HAO WU,CHUNDAO YANG
申请号:
US15538902
公开号:
US20170362242A1
申请日:
2015.12.17
申请国别(地区):
US
年份:
2017
代理人:
摘要:
The present invention provides Brutons Tyrosine Kinase (Btk) inhibitor compounds according to Formula (I), or pharmaceutically acceptable salts thereof, or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of Btk inhibitor compounds of Formula (I) in the treatment of Btk mediated disorders.